Continued Response Following Treatment with IMC-C225, an EGFr MoAb, Combined with RT in Advanced Head and Neck Malignancies.

Jason Lee, MD
OncoLink Assistant Editor
Ultima Vez Modificado: 23 de mayo del 2000

Translation for this article does not exist

Blogs

Cancer and Hair Loss
by Bob Riter
February 11, 2016